Agape ATP Corp
Key Highlights
- Revenue grew by 15% to $1.52 million in 2025.
- Diversified business model spanning health supplements and a new green energy pilot project.
- Maintained a lean operational structure with 18 full-time employees and outsourced manufacturing.
Financial Analysis
Agape ATP Corp Annual Report - How They Did This Year
I’ve put together this guide to help you understand how Agape ATP Corp performed this year. Instead of digging through dense financial filings, I’ve broken down the key facts so you can see the full picture.
1. What does this company do?
Agape ATP Corp is a "wellness ecosystem" based in Kuala Lumpur, Malaysia. They sell health supplements, including their flagship "ATP" series, and offer health screenings and consultations. Recently, they expanded into selling energy-saving devices. They operate using a multi-level marketing (MLM) model, relying on approximately 1,500 independent distributors to sell products and recruit new members.
2. How is the business structured?
The company maintains a lean team of 18 full-time employees and outsources all product manufacturing to third-party factories. Their business is divided into two segments: Health and Wellness, which generated 98% of their $1.52 million revenue in 2025, and Green Energy, a pilot project that accounted for the remaining 2%. Because they outsource production, they do not maintain direct control over their own supply chain.
3. Financial Health: The "Cash Shuffle" and Related Party Deals
The company’s 2025 finances were marked by several notable developments:
- Profitability: The company continues to operate at a loss, reporting a $2.31 million deficit for 2025. While this is a slight improvement over their $2.49 million loss in 2024, they have not yet reached profitability.
- The $23 Million Investment: The company raised $23 million through a share offering. Shortly after, they transferred $22.8 million of those proceeds to "Bi Cheng Investment Management." As of late 2025, those funds remain with the manager and are not currently generating income for the company.
- Cash Reserves: Due to the transfer mentioned above, the company’s cash reserves dropped from $2.04 million in 2024 to $140,072 in 2025, leaving a very thin margin for daily operations.
- Inside Deals: The CEO is currently owed $831,452 for an interest-free loan provided to the company. Additionally, the company paid $212,500 in rent and service fees to businesses owned by company directors.
4. Revenue Trends and Operational Risks
Revenue grew 15% to $1.52 million in 2025, but the company faces several operational hurdles:
- Reverse Stock Split: In February 2026, the company executed a 1-for-50 reverse stock split to maintain its NASDAQ listing requirements. While this increases the price per share, it does not change the underlying value of the company.
- Vendor Concentration: The business relies heavily on a small group of partners, with three vendors providing 87.4% of their products in 2025. This creates a risk where the loss of a single supplier could significantly disrupt their ability to sell products.
5. Major Risks
- "Going Concern" Warning: Auditors have issued a warning regarding the company’s ongoing losses and limited cash, noting significant doubt about the company's ability to continue as a going concern.
- Dilution: To fund operations, the company issued 46 million new shares in 2025. This increased the total share count, which reduces the ownership percentage of existing shareholders and can put downward pressure on the stock price.
- Internal Controls: Management has acknowledged that their financial reporting systems are currently ineffective. They lack an internal audit team and sufficient staff trained in U.S. accounting standards, which increases the risk of reporting errors.
Investor Takeaway: When evaluating this company, consider the balance between their revenue growth and the significant risks posed by their current cash position, reliance on related-party transactions, and the "going concern" warning from auditors. The company’s future depends heavily on its ability to stabilize its cash flow and improve its internal financial oversight.
Risk Factors
- Auditors issued a 'going concern' warning due to persistent losses and low cash reserves.
- High vendor concentration with three partners providing 87.4% of products.
- Significant dilution risk following the issuance of 46 million new shares in 2025.
- Ineffective internal financial controls and lack of U.S. accounting standard expertise.
Why This Matters
Stockadora is highlighting this report because Agape ATP Corp represents a classic 'red flag' case study for retail investors. While the company shows top-line revenue growth, the massive discrepancy between capital raised and actual cash on hand—combined with significant related-party transactions—suggests a precarious financial position.
This filing is essential reading for anyone interested in the risks of micro-cap stocks. It serves as a stark reminder that revenue growth is secondary to cash flow and internal governance when evaluating the long-term viability of a company.
Financial Metrics
Learn More
About This Analysis
AI-powered summary derived from the original SEC filing.
Document Information
SEC Filing
View Original DocumentAnalysis Processed
April 14, 2026 at 02:14 AM
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.